1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Shandong Xinhua Pharmaceutical Company Limited

Shandong Xinhua Pharmaceutical Company Limited

0719.HK
Shandong Xinhua Pharmaceutical Company LimitedHK flagHong Kong Stock Exchange
6.05
HKD
+0.23
- -
9.11BMarket Cap

Total Valuation

Shandong Xinhua Pharmaceutical Company Limited carries a market capitalization of 9.11B, placing it among publicly traded companies globally. Its enterprise value stands at 4.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap9.11B
Enterprise Value4.70B

Share Statistics

Shandong Xinhua Pharmaceutical Company Limited currently has 689.78M shares outstanding.

Shares Outstanding689.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Shandong Xinhua Pharmaceutical Company Limited trades at a trailing price-to-earnings ratio of 10.01. The price-to-sales ratio is 0.51, and the price-to-book ratio stands at 1.30.

PE Ratio10.01
PS Ratio0.51
PB Ratio1.30
P/TBV Ratio0.89
P/FCF Ratio22.33
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Shandong Xinhua Pharmaceutical Company Limited trades at an EV/EBITDA multiple of 8.29 and an EV/FCF ratio of 20.35. The EV/Sales ratio of 0.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.29 provides insight into valuation relative to core operating earnings.

EV / Sales0.56
EV / EBITDA8.29
EV / EBIT8.29
EV / FCF20.35

Financial Position

Shandong Xinhua Pharmaceutical Company Limited maintains a current ratio of 1.27, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 27.05, indicating elevated leverage, while an interest coverage ratio of 13.10 demonstrates strong ability to service its debt obligations.

Current Ratio1.27
Quick Ratio0.40
Debt / Equity27.05
Debt / EBITDA2.56
Interest Coverage13.10

Financial Efficiency

Shandong Xinhua Pharmaceutical Company Limited posts a return on equity of 13.44 and a return on invested capital of 7.74.

Return on Equity (ROE)13.44
Return on Assets (ROA)4.77
Return on Invested Capital (ROIC)7.74
Return on Capital Employed (ROCE)9.31
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.44

Taxes

Over the trailing twelve months, Shandong Xinhua Pharmaceutical Company Limited has paid 48.70M in income taxes, reflecting an effective tax rate of 9.86.

Income Tax48.70M
Effective Tax Rate9.86

Stock Price Statistics

Shandong Xinhua Pharmaceutical Company Limited's stock has declined approximately -15.02809% over the past 52 weeks. The 50-day moving average sits at 6.01, while the 200-day moving average is 6.68.

Beta (5Y)N/A
52-Week Price Change-15.02809%
50-Day Moving Average6.01
200-Day Moving Average6.68
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Shandong Xinhua Pharmaceutical Company Limited generated 8.37B in revenue and converted that into 428.38M in net income, yielding earnings per share of 0.60. EBITDA reached 567.35M, while operating income came in at 567.35M.

Revenue8.37B
Gross Profit1.79B
Operating Income567.35M
Pretax Income493.82M
Net Income428.38M
EBITDA567.35M
EBIT567.35M
Earnings Per Share (EPS)0.60

Balance Sheet

Shandong Xinhua Pharmaceutical Company Limited holds 1.28B in cash and equivalents against 1.45B in total debt, resulting in a net debt position of -531.77M. Total book value stands at 3.29B, with working capital of 839.89M providing operational flexibility.

Cash & Cash Equivalents1.28B
Total Debt1.45B
Net Debt-531.77M
Equity (Book Value)3.29B
Book Value Per Share4.40
Working Capital839.89M

Cash Flow

After subtracting -192.08M in capital expenditures, free cash flow totaled -192.08M - equivalent to -0.26 per share.

Operating Cash FlowN/A
Capital Expenditures-192.08M
Free Cash Flow-192.08M
FCF Per Share-0.26

Margins

Shandong Xinhua Pharmaceutical Company Limited operates with a gross margin of 21.34, reflecting its pricing power and cost economics. The operating margin of 6.78 and net profit margin of 5.12 provide insight into operational efficiency.

Gross Margin21.34
Operating Margin6.78
Pretax Margin5.90
Profit Margin5.12
EBITDA Margin6.78

Dividends & Yields

The company's payout ratio of 49.71 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.31
Dividend YieldN/A
Payout Ratio49.71
Shareholder Yield0.67
FCF Yield4.48

Stock Splits

Shandong Xinhua Pharmaceutical Company Limited's most recent stock split took place on July 6, 2018 with a 10:13 split ratio.

Last Split Date7/6/2018
Split Ratio10:13

Scores

Shandong Xinhua Pharmaceutical Company Limited posts an Altman Z-Score of 2.38, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.38